Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 50, Pages E5401-E5410
Publisher
Proceedings of the National Academy of Sciences
Online
2014-12-03
DOI
10.1073/pnas.1407792111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms
- (2013) J. A. Kennedy et al. BLOOD
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia
- (2012) A. Eghtedar et al. BLOOD
- Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome
- (2012) S.-J. Zhang et al. BLOOD
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
- (2011) T. Klampfl et al. BLOOD
- Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
- (2011) Kamalika Moulick et al. Nature Chemical Biology
- p53 Lesions in Leukemic Transformation
- (2011) Ashot Harutyunyan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
- (2010) P. Koppikar et al. BLOOD
- Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)
- (2010) S. Thepot et al. BLOOD
- Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2010) N. H. Thoennissen et al. BLOOD
- Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
- (2010) O. Abdel-Wahab et al. CANCER RESEARCH
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic options for patients with myelofibrosis in blast phase
- (2010) John Mascarenhas et al. LEUKEMIA RESEARCH
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
- (2010) Anthony Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
- (2009) P. A. Beer et al. BLOOD
- p53 Regulates Hematopoietic Stem Cell Quiescence
- (2009) Yan Liu et al. Cell Stem Cell
- AML transformation in 56 patients with Ph− MPD in two well defined populations
- (2008) Khadija Abdulkarim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started